drugset / Trial / NCT00238732

Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause

NCT00238732

Phase 3 Completed 650 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
RandomizedSingle-groupDouble-blindDiagnostic

Summary

The purpose of this study is to determine whether Bazedoxifine/conjugated estrogens are effective in the treatment of vaginal atrophy.

Timeline

Start
2005-10
Primary completion
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Bazedoxifene Other / unclassified
Subject conjugated estrogens Other / unclassified